Kaynes Technology India Limited (KAYNES)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 consolidated revenue INR9,525 mn; EBITDA INR1,256 mn (13.2% margin); PAT INR398 mn
- H1 FY27 revenue INR18,987 mn; EBITDA INR2,681 mn (14.1% margin)
- Order book robust at ~INR105,635 mn; focus on balance sheet strength and cash discipline
- OSAT and PCB Unit 2 operational; Vishay JV to use 75-90% capacity, accelerating scale
- Smart Meter revenue down 80% in Q2 to prioritize balance sheet; receivables reduced from INR1,402 cr to INR1,091 cr
- EMS business grew 34% in Q2, margins improving via VAVE; aiming 30%+ growth FY27
- Capex INR221 cr in Q2, focused on Semicon, Circuits, EMS; no QIP planned next 12 months
- Strategic focus on aerospace, railways, medical electronics; global footprint expansion ongoing
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KAYNES — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KAYNES to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Kaynes Technology India Limited
Important.
The summary above is generated automatically from Kaynes Technology India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.